About Us

Comprehensive Preclinical CRO

MORE ABOUT US

Comprehensive Preclinical CRO

KCI Biotech is a preclinical CRO with 40,000+㎡ of AAALAC-accredited facilities. Our platforms support multiple species, 500+ disease models, and BSL-2/ABSL-2 pathogen research covering 100+ microorganisms, along with pathology and toxicology services. With 1,000+ partners and 200+ regulatory projects, we are recognized among the top CRO companies for comprehensive drug development expertise.

OUR TEAM

Our experts

Sit non mauris aenean sem platea tortor est. Tincidunt elit ut varius sit sit lorem aliquam. Morbi metus sem elit dignissim.

10000m2 Small animal experimental base of KCI Biotech CRO Company in Suzhou, China

Suzhou site
Small Animal Laboratory
10000㎡

Nantong-Haimen site
Large Animal Laboratory
7600㎡

22000m2 Large animal production base of KCI Biotech CRO Company in Nantong, China

Nantong-Haimen site
Animal Breeding Center
22000㎡

Integrity, professionalism and efficiency

BEFORE YOU START

Faster, easier and safer than ever

Duis ornare vehicula sodales dui sed parturient nunc. Nisi, in
porta tristique id pharetra viverra sed erat. Habitant non mollis
a sed id imperdiet ornare.

Company history

Development Course

Why us

Corporate Culture

Qualifications

Help the global research and development of new drugs